SABR in early operable lung cancer: time for evidence
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference9 articles.
1. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials;Chang;Lancet Oncol,2015
2. Restoring invisible and abandoned trials: a call for people to publish the findings;Doshi;BMJ,2013
3. Statistical assessment of the learning curves of health technologies;Ramsay;Health Technol Assess,2001
4. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer;Wu;Lung Cancer,2002
5. Caveat emptor: the treachery of work-up bias;Blackstone;J Thorac Cardiovasc Surg,2004
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC;Journal of Thoracic Oncology;2020-02
2. Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future;General Thoracic and Cardiovascular Surgery;2019-10-30
3. SABR in clinical trials: what quality assurance (QA) is required and how can it be done?;Journal of Physics: Conference Series;2019-01
4. Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey;Advances in Radiation Oncology;2018-04
5. Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making;BMC Cancer;2018-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3